Exome sequencing allows for rapid gene identification in a Charcot-Marie-Tooth family.
Gladys Montenegro, Eric Powell, Jia Huang...
https://pubmed.ncbi.nlm.nih.gov/21254193/Actively Recruiting
Led by University of Iowa · Updated on 2026-10-27
1050
Participants Needed
24
Research Sites
N/A
Total Duration
Researchers are studying Charcot-Marie-Tooth disease CMT, focusing on finding new genes that cause the disease and identifying genes that may modify symptoms in people with CMT. This project includes participants who have either CMT type 1A or an unknown form of CMT. The goal is to better understand how genetic factors influence the severity of the disease and to discover new genetic causes that have not yet been identified. Participants will provide blood samples, which will be sent to the University of Miami for exome sequencing to analyze their genetic information. This genetic testing is optional for participants. The study groups include families or individuals with genetically defined CMT1A and those with genetically undefined CMT where common causes have been ruled out. During the study, participants will be assessed through their genetic data, with researchers focusing on gene modifiers of CMT1A and new genetic causes of CMT. There are no interventions or treatments given, as this is an observational study. The study is expected to continue until December 2030, and participants may be contacted for follow-up as needed based on the research progress.
CONDITIONS
Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2
T
Tiffany Grider, MS, CGC
N
Nicole Kressin, MSN, RN
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Iowa
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote)
Duration - Ongoing until study completion
Participants provide a blood sample for optional genetic testing and share medical and family history information. No treatment is given.
1 visit for sample collection and data gathering
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Gladys Montenegro, Eric Powell, Jia Huang...
https://pubmed.ncbi.nlm.nih.gov/21254193/University of Iowa
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborating Sponsor